PJ ‑001, a small‑molecule proteolysis‑targeting chimera, ameliorates atopic dermatitis‑like inflammation in mice by inhibiting the JAK2/STAT3 pathway and repairing the skin barrier

In conclusion, PJ-001 could be considered a potential therapeutic option for AD.PMID:38476907 | PMC:PMC10928824 | DOI:10.3892/etm.2024.12464

Source: Experimental and Therapeutic Medicine - March 13, 2024 Category: General Medicine Authors: Pei Lin Zhendong Chen Yinying Lu Hongyu Shi Jun Lin Source Type: research